Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

ER 001533 MeSH Supplementary Concept Data 2025


MeSH Supplementary
ER 001533
Unique ID
C074219
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C074219
Entry Term(s)
ER-001533
N-(3-((N'-(2-(3,5-dimethoxyphenyl)ethyl)-N'-methyl)amino)propyl)-4-(4-(N(3)-methyl-N(2)-cyanoguanidino)phenyl)-3-butenamide oxalate
Registry Numbers
142808-46-6
CAS Type 1 Name
3-Butenamide, 4-(4-(((cyanoamino)(methylamino)methylene)amino)phenyl)-N-(3-((2-(3,5-dimethoxyphenyl)ethyl)methylamino)propyl)-, ethanedioate (1:1)
Heading Mapped to
*Guanidines
*Phenylbutyrates
Frequency
2
Note
structure given in first source; a newly synthesized vasorelaxant
Source
Circ Res 1992 May;70(5):1054-61
Date of Entry
1992/05/26
Revision Date
2001/03/27
ER 001533 Preferred
N-(3-((N'-(2-(3,5-dimethoxyphenyl)ethyl)-N'-methyl)amino)propyl)-4-(4-(N(3)-methyl-N(2)-cyanoguanidino)phenyl)-3-butenamide oxalate Broader
page delivered in 0.006s